StockMarketWire.com - JP Morgan Cazenove today initiates coverage of Dechra Pharmaceuticals PLC [LON:DPH] with a overweight investment rating and price target of 3000p.

Story provided by StockMarketWire.com

Broker Forecasts data provided by www.sharesmagazine.co.uk